National and subnational survey on diabetes burden and quality of care index in Iran: a systematic analysis of the global burden of disease study 1990–2019

Mousavi, Seyedeh Farzaneh; Peimani, Maryam; Moghaddam, Sahar Saeedi; Tabatabaei‐Malazy, Ozra; Ghasemi, Erfan; Shobeiri, Parnian; Rezaei, Negar; Nasli‐Esfahani, Ensieh; Larijani, Bagher

doi:10.1007/s40200-022-01108-x

Cited by 6 publications

(3 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Building better healthcare infrastructure, improving standardized treatment services, implementing coordinated multilevel interventions to reduce geographic disparities in care, and using digital technology such as virtual clinics could help to increase awareness, treatment, and control of diabetes [ 7 , 8 , 29 ]. Moreover, an adopted national clinical practice guideline that considers limited local resources and some problems in accessing Iranian patients’ anti-diabetic drugs, especially modern treatments due to sanctions, should be prepared and regularly updated [ 35 , 36 ].…”

Section: Discussionmentioning

confidence: 99%

Inequalities in the prevalence, diagnosis awareness, treatment coverage and effective control of diabetes: a small area estimation analysis in Iran

et al. 2023

Self Cite

View full text Add to dashboard Cite

Objective This study aims to assess geographic inequalities in the prevalence, awareness of diagnosis, treatment coverage and effective control of diabetes in 429 districts of Iran. Methods A modelling study by the small area estimation method, based on a nationwide cross-sectional survey, Iran STEPwise approach to surveillance (STEPS) 2016, was performed. The modelling estimated the prevalence, awareness of diagnosis, treatment coverage, and effective control of diabetes in all 429 districts of Iran based on data from available districts. The modelling results were provided in different geographical and socio-economic scales to make the comparison possible across the country. Results In 2016, the prevalence of diabetes ranged from 3.2 to 19.8% for women and 2.4 to 19.1% for men. The awareness of diagnosis ranged from 51.9 to 95.7% for women and 35.7 to 100% for men. The rate of treatment coverage ranged from 37.2 to 85.6% for women and 24.4 to 80.5% for men. The rate of effective control ranged from 12.1 to 63.6% for women and 12 to 73% for men. The highest treatment coverage rates belonged to Ardebil for women and Shahr-e-kord for men. The highest effective control rates belonged to Sanandaj for women and Nehbandan for men. Across Iran districts, there were considerable differences between the highest and lowest rates of prevalence, diagnosis awareness, treatment coverage, and effective control of diabetes. The concentration indices of diabetes prevalence, awareness of diagnosis, and treatment coverage were positive and significant for both sexes. Conclusion Findings of this study highlight the existence of inequalities in diagnosis awareness, treatment coverage, and effective control of diabetes in all Iran regions. More suitable population-wide strategies and policies are warranted to handle these inequalities in Iran.

show abstract

Section: Discussionmentioning

confidence: 99%

Inequalities in the prevalence, diagnosis awareness, treatment coverage and effective control of diabetes: a small area estimation analysis in Iran

et al. 2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…Type 2 diabetes mellitus (T2DM) presents as a major health problem worldwide with an incidence of approximately 10%, which is projected to reach 783 million by 2045 . In 2017, approximately 5 million deaths of people in the 18–99 year age range worldwide were attributable to diabetes.…”

Section: Introductionmentioning

confidence: 99%

Ginsenoside F4 Alleviates Skeletal Muscle Insulin Resistance by Regulating PTP1B in Type II Diabetes Mellitus

Zhao,

Liu,

Deng

et al. 2023

J. Agric. Food Chem.

View full text Add to dashboard Cite

“…Iran is also a developing country experiencing an epidemiological transitional period toward modernization in the contemporary age and is dealing with the increasing burden of various NCDs and the responsible risk factors ( 3 , 4 ). The most burdensome NCDs nationally in Iran have been ischemic heart disease, stroke, and diabetes mellitus based on the most recent estimations, with diverse epidemiology subnationally and for different socio-demographic stratifications of the Iranian population ( 5 – 8 ). Furthermore, among these top causes of NCDs burden in the country, ischemic heart disease was the prominent cause of burden in all provinces showing the heavy ongoing burden of this cause in the country ( 6 ).…”

Section: Introductionmentioning

confidence: 99%

Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019

Moradi¹,

Nasri²,

Moghaddam³

et al. 2023

Front. Public Health

Self Cite

View full text Add to dashboard Cite

IntroductionMetabolic risk factors (MRFs) predispose populations to a variety of chronic diseases with a huge burden globally. With the increasing burden of these risk factors in Iran, in this study, we aimed to report the estimated burden attributed to MRFs at national and subnational scales in Iran, from 1990 to 2019.MethodsBased on the comparative risk assessment method of the Global Burden of Disease (GBD) Study 2019, data of deaths and disability-adjusted life years (DALYs) attributable to four top MRFs in Iran including high systolic blood pressure (SBP), high fasting plasma glucose (FPG), high body mass index (BMI), and high low-density lipoprotein (LDL) for the 1990–2019 period, were extracted. The socio-demographic index (SDI) was used to report the data based on the corresponding socio-economic stratifications. The results were reported in national and subnational 31 provinces of Iran to discover disparities regarding the attributable burden to MRFs. Furthermore, we reported the causes of diseases to which the attributable burden to MRFs was related.ResultsOverall, the age-standardized high LDL, high SBP, high BMI, and high FPG-attributed death rate changed by −45.1, −35.6, +2.8, and +19.9% from 1990 to 2019, respectively. High SBP was the leading risk factor regarding attributed age-standardized death rates reaching 157.8 (95% uncertainty interval: 135.3–179.1) and DALY rates reaching 2973.4 (2652.2–3280.2) per 100,000 person-years, in 2019. All rates increased with aging, and men had higher rates except for the +70 years age group. At the subnational level, provinces in the middle SDI quintile had the highest death and DALY rates regarding all four MRFs. Total deaths, DALYs, YLLs and YLDs number by the causes of diseases linked to MRFs increased over the study period. Cardiovascular diseases, diabetes mellitus, and kidney diseases were the main causes of burden of disease attributable to MRFs.ConclusionHerein, we found divergent patterns regarding the burden of MRFs as well as disparities in different regions, sex, and age groups for each risk factor and related causes. This could provide policymakers with a clearer vision toward more appropriate decision-making and resource allocation to prevent the burden of MRFs in Iran.

show abstract

National and subnational survey on diabetes burden and quality of care index in Iran: a systematic analysis of the global burden of disease study 1990–2019

Cited by 6 publications

References 42 publications

Inequalities in the prevalence, diagnosis awareness, treatment coverage and effective control of diabetes: a small area estimation analysis in Iran

Inequalities in the prevalence, diagnosis awareness, treatment coverage and effective control of diabetes: a small area estimation analysis in Iran

Ginsenoside F4 Alleviates Skeletal Muscle Insulin Resistance by Regulating PTP1B in Type II Diabetes Mellitus

Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019

Contact Info

Product

Resources

About